Skip to content
Trial Agents

FGK Clinical Research Sp. z o.o

FGK Clinical Research Sp. z o.o is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.

3distinct trials
4recorded service labels
0trials with learnings

Data snapshot: 2026-10-09 · About the data

Clinical trial experience

Showing 3 of 3 trials · Latest update first

A Pivotal, Randomized, Placebo-Controlled, Double-Blind, Multicenter, International Phase III Clinical Trial to Investigate the Efficacy and Safety of allo-APZ2-CVU on Wound Healing of Therapy-Resistant Non-Healing Chronic Venous Ulcers (CVU)

Sponsor Rheacell GmbH & Co. KG

Start (EU)
Latest update
Estimated end

Questions about this trial experience

What services are recorded for FGK Clinical Research Sp. z o.o?

The 2026-10-09 snapshot links FGK Clinical Research Sp. z o.o to 3 distinct CTIS trials. Recorded services include Clinical monitoring, Regulatory services, Investigator recruitment, Medical writing. These are study-specific roles, not a complete or independently verified capability catalogue.

Which therapeutic areas and study phases are recorded for FGK Clinical Research Sp. z o.o?

The most frequently recorded therapeutic areas are Dermatology. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.

In which countries are trials linked to FGK Clinical Research Sp. z o.o conducted?

The linked trials record locations in 10 countries, including Germany, Poland, Austria, Czechia, Hungary. These are trial locations, not confirmed office locations or countries where FGK Clinical Research Sp. z o.o delivered services.

What can this page tell me about FGK Clinical Research Sp. z o.o's trial experience?

Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.

About this data & company names

One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.

Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.

Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under FGK Clinical Research Sp. z o.o. Legacy brands remain separate unless explicitly matched in the name registry.

View recorded company names
  • FGK Clinical Research Sp. z o.o.

Never miss a new clinical trial insight

We continuously analyze new and updated clinical trial data and publish practical, evidence-led reports for clinical leaders.